How do mutations in the BRCA1 and BRCA2 genes affect cancer risk?

How do mutations in the BRCA1 and BRCA2 genes affect cancer risk?

• A. They primarily lead to lung cancer
• B. They increase the risk of breast and ovarian cancers
• C. They decrease overall cancer risk
• D. They have no effect on cancer risk levels

Answer: (B)

Mutations in the BRCA1 and BRCA2 genes are specifically linked to an increased risk of developing breast and ovarian cancers. These genes are crucial for the repair of DNA breaks through a process known as homologous recombination, which is essential for maintaining genomic stability. When these genes are mutated, the ability of cells to repair DNA damage is compromised, leading to the accumulation of genetic alterations that can result in cancer. It is particularly well-established that women with BRCA1 mutations have a significantly higher risk of breast and ovarian cancers, and BRCA2 mutations also confer a substantial risk for these cancers, as well as for other types of cancer such as pancreatic and prostate cancers. This connection between BRCA mutations and specific cancer risks is backed by extensive research, making it clear that these mutations are critical factors in assessing cancer risk for individuals.

Mutations in the BRCA1 and BRCA2 genes are specifically linked to an increased risk of developing breast and ovarian cancers. These genes are crucial for the repair of DNA breaks through a process known as homologous recombination, which is essential for maintaining genomic stability. When these genes are mutated, the ability of cells to repair DNA damage is compromised, leading to the accumulation of genetic alterations that can result in cancer. It is particularly well-established that women with BRCA1 mutations have a significantly higher risk of breast and ovarian cancers, and BRCA2 mutations also confer a substantial risk for these cancers, as well as for other types of cancer such as pancreatic and prostate cancers. This connection between BRCA mutations and specific cancer risks is backed by extensive research, making it clear that these mutations are critical factors in assessing cancer risk for individuals.